Envigo Research Private Limited logo

Envigo Research Private Limited

Provides research animal breeding and sales, contract research services, and supplies for research animal care.
2013 | Ahmedabad, Gujarat (India) | Under Liquidation

Last Updated:

May 04, 2024
HomeCompanyEnvigo Research Private Limited

Who are the key members and board of directors at Envigo Research?

Board Members(2)

NameDesignationAppointment DateStatus
Michael Oreilly Gb Director 12-Dec-2014Current
Hemendra Nagori In Director 14-Feb-2019Current

Financial Performance of Envigo Research.

Envigo Research Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 41.6% decrease. The company also saw a substantial fall in profitability, with a 1367.73% decrease in profit. The company's net worth observed a substantial decline by a decrease of 137.31%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-41.60%
Revenue from Operations
-39.72%
Total Assets
-35.01%
Profit or Loss
-1367.73%
Net Worth
-137.31%
EBITDA
-1115.85%

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Envigo Research?

Envigo Research has a workforce of 2 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Envigo Research

Recent activity within the organization

  • Annual General Meeting

    Envigo Research Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

    30 Sep 2022

  • Balance Sheet

    Envigo Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ahmedabad.

    31 Mar 2022

  • Director Appointment

    Hemendra Ishverlal Nagori was appointed as a Director was appointed as a Director on 14 Feb 2019 & has been associated with this company since 5 years 10 months .

    14 Feb 2019

  • Director Appointment

    Michael Gregory Oreilly was appointed as a Director was appointed as a Director on 12 Dec 2014 & has been associated with this company since 10 years 13 days .

    12 Dec 2014

  • Company Incorporation

    Envigo Research Private Limited was registered on 05 Apr 2013 with Roc Ahmedabad & aged 11 years 8 months as per MCA records.

    05 Apr 2013

Frequently asked questions

  • Envigo Research Private Limited was incorporated on 05 Apr 2013.

  • The authorized share capital of Envigo Research Private Limited is ₹ 19.00 Cr and paid-up capital is ₹ 17.73 Cr.

  • Currently 2 directors are associated with Envigo Research Private Limited.

    • Michael Gregory Oreilly
    • Hemendra Ishverlal Nagori
  • As per Ministry of Corporate Affairs (Mca), the registered address of Envigo Research Private Limited is D/502 Riddhi Tower Falgun Tenament Pachhal, Jodhpur Gam Satellite, Ahmedabad, Gujarat, India, 380015.

  • The corporate identification number (CIN) of Envigo Research Private Limited is U73100GJ2013FTC074361 and the company number is 074361 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Envigo Research Private Limited is https://www.harlan.com

  • According to the financial reports for the fiscal year 2018, the revenue trend for Envigo Research Private Limited has fallen by -41.60%.

  • As Per 2018 financial reports, 2 employees are currently employed by Envigo Research Private Limited.

  • The financial reports for the fiscal year 2018 indicates that The net worth of Envigo Research Private Limited has experienced an downturn of -137.31%.

  • The most recent Balance Sheet for Envigo Research Private Limited was filed with the ROC on 31 Mar 2022.

Similar Companies Based on Pharma Contract R&D